Cigarette smoking is the major environmental risk factor for the development of chronic obstructive pulmonary disease (COPD); however, only a subset of smokers develop clinically significant COPD. In addition to the risk from smoking, subjects with severe alpha 1-antitrypsin deficiency have a major genetic predisposition to COPD; other genetic determinants of COPD have not been proven. The frequent development of COPD in individuals with alpha 1-antitrypsin deficiency has provided a foundation for the protease-antiprotease hypothesis for the pathogenesis of COPD. However, many subjects with severe, early-onset COPD are not alpha 1-antitrypsin deficient. To define the mechanisms responsible for the development of severe, early-onset COPD unrelated to alpha 1-antitrypsin deficiency, we propose a multidisciplinary study that combines field, laboratory, and analytical approaches. We will assemble a group of 140 pedigrees ascertained through probands with severe, early-onset COPD (without severe alpha 1-antitrypsin deficiency) who are referred for lung transplant or lung volume reduction surgery evaluations. We will assess these probands and their relatives with spirometry (including bronchodilator response) and a questionnaire. We will obtain genotyping with highly polymorphic short tandem repeat (STR) markers at 10 cM intervals throughout the genome from the NHLBI Mammalian Genotyping Service; these genotypes will be used to assess for genetic linkage to phenotypes including FEV1, FEV1/FVC, chronic bronchitis, and bronchodilator responsiveness. In chromosomal regions with suggestive linkage from the genome screen, additional STR markers will be tested at 1 cM intervals; multipoint linkage analysis, family-based association studies, and haplotype analysis will be used to narrow the regions likely to contain genetic determinants of COPD-related phenotypes. mRNA levels of genes within these regions narrowed by fine mapping will be compared in lung tissue from early-onset COPD probands and control subjects. The results of this study could identify specific regions of the genome which are likely to contain COPD susceptibility genes and provide candidate susceptibility genes for COPD. Identification of such genetic determinants could provide insight into the biochemical mechanisms causing the variable development of COPD at all ages, allow identification of highly susceptible individuals, and lead to new therapeutic interventions for COPD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061575-04
Application #
6537490
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Croxton, Thomas
Project Start
1999-08-16
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
4
Fiscal Year
2002
Total Cost
$274,458
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Hersh, Craig P; Demeo, Dawn L; Lazarus, Ross et al. (2006) Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:977-84
Demeo, Dawn L; Mariani, Thomas J; Lange, Christoph et al. (2006) The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet 78:253-64
Hersh, C P; Miller, D T; Kwiatkowski, D J et al. (2006) Genetic determinants of C-reactive protein in COPD. Eur Respir J 28:1156-62
Kelleher, Cassandra M; Silverman, Edwin K; Broekelmann, Thomas et al. (2005) A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 33:355-62
DeMeo, Dawn L; Reilly, John J; Ginns, Leo C et al. (2005) Concordance of genotypes in pre- and post-lung transplantation DNA samples. Am J Respir Cell Mol Biol 33:402-5
Hersh, Craig P; Demeo, Dawn L; Lange, Christoph et al. (2005) Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 33:71-8
DeMeo, D L; Carey, V J; Chapman, H A et al. (2004) Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD. Thorax 59:396-400
Hersh, Craig P; DeMeo, Dawn L; Al-Ansari, Essam et al. (2004) Predictors of survival in severe, early onset COPD. Chest 126:1443-51
Celedon, Juan C; Lange, Christoph; Raby, Benjamin A et al. (2004) The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 13:1649-56
DeMeo, Dawn L; Celedon, Juan C; Lange, Christoph et al. (2004) Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170:1294-301

Showing the most recent 10 out of 20 publications